Dapsone Hypersensitivity Syndrome With Leukemoid Reaction and Severe Thrombocytosis

  • Pahadiya H
  • Lakhotia M
N/ACitations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Hypersensitivity reactions to dapsone are common and potentially fatal adverse drug reactions. Herein, we report a case of a 45-year-old female who presented with fever, generalized desquamating rashes, and icterus three weeks after initiation of dapsone therapy for leprosy neuritis. She was diagnosed to have dapsone hypersensitivity syndrome (DHS) with leukemoid reaction and thrombocytosis. Dapsone was immediately discontinued, and she has treated with prednisolone 50 mg daily for a month and tapered over the next month. She has improved completely. DHS, leukemoid reaction, and severe thrombocytosis, or these adverse drug reactions to dapsone have rarely been reported.

Cite

CITATION STYLE

APA

Pahadiya, H. R., & Lakhotia, M. (2021). Dapsone Hypersensitivity Syndrome With Leukemoid Reaction and Severe Thrombocytosis. Cureus. https://doi.org/10.7759/cureus.14026

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free